Ersodetug, a novel, fully human monoclonal antibody for the treatment of hyperinsulinism (HI), receives Breakthrough Therapy Designation and Orphan Drug Designation Open-label arm (infant participants ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback